TG Therap
TGTX54.8701.58% ( -0.880 )
TG Therap (TGTX)
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-ce...
- Open
- 56.000
- High
- 56.281
- Low
- 54.610
- Prev. Close
- 55.750
- Volume
- 2.33M
- Turnover
- 128.27M
- Avg Price
- 55.137
- Bid/Ask Ratio
- --
- Amplitude
- 3.00%
- 52wk High
- 59.300
- Volume Ratio
- 1.29
- Turnover Ratio
- 1.52%
TG Therap Analyst Rating
View MoreForecast & Rating
Jul 27, 2026Price forecast
$68.4324.71%
Forecast & RatingBuy
8analysts
- Strong buy75.00%
- Buy12.50%
- Hold0.00%
- Sell0.00%
- Strong sell12.50%
News
- Global Report · Jul 26 at 04:15 AM
Mid-Cap Tech and Healthcare Face Critical Tests: From Delisting Risks to Mega Financings
- Global Report · Jul 25 at 04:13 AM
Navigating Cross-Border Currents: Sector Divergence and Strategic Pivots in a Fragmented 2026 Market
- Global Report · Jul 24 at 04:12 AM
Divergent Signals: Niche Equities Show Idiosyncratic Resilience Amid Macro Uncertainty
- prnewswire · Jul 21 at 04:21 PM
17:20 ETKuehn Law Encourages Investors of TG Therapeutics, Inc. to Contact Law Firm
- rttnews · Jul 13 at 03:59 AM
Returns Matter: NUTX +214%, CORT +145%, GKOS +97% - Were These Biotech Stocks In Your Portfolio?
- MSN · Jul 8 at 08:33 PM
2 fast-growing pharmaceutical stocks to buy now
